IL151167A0 - Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same - Google Patents

Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL151167A0
IL151167A0 IL15116701A IL15116701A IL151167A0 IL 151167 A0 IL151167 A0 IL 151167A0 IL 15116701 A IL15116701 A IL 15116701A IL 15116701 A IL15116701 A IL 15116701A IL 151167 A0 IL151167 A0 IL 151167A0
Authority
IL
Israel
Prior art keywords
group
optionally substituted
medicament
pyrrolopyridazine
cycloalkyl
Prior art date
Application number
IL15116701A
Other languages
English (en)
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Publication of IL151167A0 publication Critical patent/IL151167A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL15116701A 2000-02-10 2001-02-06 Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same IL151167A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000033627 2000-02-10
PCT/JP2001/000820 WO2001058901A1 (fr) 2000-02-10 2001-02-06 Compose de pyrrolopyridazine

Publications (1)

Publication Number Publication Date
IL151167A0 true IL151167A0 (en) 2003-04-10

Family

ID=18558082

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15116701A IL151167A0 (en) 2000-02-10 2001-02-06 Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same

Country Status (21)

Country Link
US (1) US6734181B2 (ru)
EP (1) EP1254907B1 (ru)
KR (1) KR100750551B1 (ru)
CN (1) CN1285593C (ru)
AT (1) ATE361925T1 (ru)
AU (2) AU3058501A (ru)
BR (1) BR0108251A (ru)
CA (1) CA2399380A1 (ru)
CZ (1) CZ20022742A3 (ru)
DE (1) DE60128329T2 (ru)
ES (1) ES2286094T3 (ru)
HK (1) HK1049163B (ru)
HU (1) HUP0204579A3 (ru)
IL (1) IL151167A0 (ru)
MX (1) MXPA02007799A (ru)
NO (1) NO20023771L (ru)
NZ (1) NZ520606A (ru)
PL (1) PL358014A1 (ru)
RU (1) RU2254335C2 (ru)
WO (1) WO2001058901A1 (ru)
ZA (1) ZA200206196B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418479A (en) * 2002-09-25 2004-10-01 Sankyo Co Pharmaceutical compositions for the treatment or prevention of visceral pains
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
KR20070053231A (ko) * 2004-07-28 2007-05-23 다케다 야쿠힌 고교 가부시키가이샤 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도
WO2006038773A1 (en) * 2004-09-03 2006-04-13 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7754691A (en) 1990-04-27 1991-11-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel pyridazines
WO1992006979A1 (de) 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
ATE179419T1 (de) * 1991-10-25 1999-05-15 Byk Gulden Lomberg Chem Fab Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
JP3143571B2 (ja) * 1994-01-19 2001-03-07 三共株式会社 ピロロピリダジン誘導体
ATE229020T1 (de) * 1994-01-19 2002-12-15 Sankyo Co Pyrrolopyridazin-derivate
US5753664A (en) 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
JPH0995485A (ja) * 1995-03-16 1997-04-08 Takeda Chem Ind Ltd 複素環化合物、その製造法および剤
TWI287014B (en) 1999-06-15 2007-09-21 Sankyo Co Optically active pyrrolopyridazine compound

Also Published As

Publication number Publication date
NZ520606A (en) 2004-06-25
KR20020072579A (ko) 2002-09-16
CA2399380A1 (en) 2001-08-16
CN1422272A (zh) 2003-06-04
CN1285593C (zh) 2006-11-22
HUP0204579A3 (en) 2006-01-30
NO20023771D0 (no) 2002-08-09
WO2001058901A1 (fr) 2001-08-16
KR100750551B1 (ko) 2007-08-20
HK1049163B (zh) 2007-09-28
EP1254907A1 (en) 2002-11-06
ES2286094T3 (es) 2007-12-01
DE60128329D1 (de) 2007-06-21
ATE361925T1 (de) 2007-06-15
CZ20022742A3 (cs) 2003-02-12
RU2254335C2 (ru) 2005-06-20
AU2001230585B2 (en) 2005-01-06
NO20023771L (no) 2002-10-09
US20040014762A1 (en) 2004-01-22
DE60128329T2 (de) 2008-01-10
HUP0204579A2 (hu) 2003-04-28
HK1049163A1 (en) 2003-05-02
EP1254907B1 (en) 2007-05-09
RU2002121482A (ru) 2004-01-10
EP1254907A4 (en) 2004-11-24
MXPA02007799A (es) 2002-10-17
BR0108251A (pt) 2003-03-25
PL358014A1 (en) 2004-08-09
ZA200206196B (en) 2003-11-03
AU3058501A (en) 2001-08-20
US6734181B2 (en) 2004-05-11

Similar Documents

Publication Publication Date Title
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
TW200745033A (en) Oxindole derivative as feeding control agent
WO2003049690A3 (en) Hiv integrase inhibitors
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
IL151167A0 (en) Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same
DE60123827D1 (en) 1-methylcarbapenemderivate
AU6731100A (en) Integrase inhibitors containing aromatic heterocycle derivatives
NZ517315A (en) New derivatives of A-500359
IL147088A0 (en) Optically active pyrrolpyridazine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
WO2000078793A3 (en) Antimicrobial agents
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.